Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA synthesis machinery encompasses the molecular components responsible for transcribing DNA into RNA. The core enzyme is RNA polymerase, with eukaryotic cells possessing three main types: RNA Polymerase I (rRNA synthesis), RNA Polymerase II (mRNA and some snRNA synthesis), and RNA Polymerase III (tRNA, 5S rRNA, and other small RNA synthesis). These polymerases are multi-subunit complexes requiring accessory factors for proper function. The machinery catalyzes RNA strand formation complementary to DNA, involving initiation, elongation, and termination. Products are essential for gene expression, with mRNAs serving as templates for protein synthesis, rRNAs forming ribosomes, and tRNAs delivering amino acids. Errors can lead to diseases like Diamond Blackfan anemia or Dyskeratosis congenita. Many antibiotics target bacterial ribosomal RNAs, inhibiting protein production, highlighting the machinery's importance as a drug target.
Inhibition of transcription, Inhibition of translation (in bacteria), Modulation of protein-RNA interactions
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA Synthesis Machinery.